5/25/2017 | SP | New Issue: UBS prices $477,000 trigger phoenix autocallables linked to CVS
|
5/25/2017 | SP | New Issue: UBS prices $387,000 trigger phoenix autocallables linked to CVS
|
5/25/2017 | SP | New Issue: UBS prices $769,000 trigger phoenix autocallables linked to CVS
|
2/9/2017 | SP | New Issue: UBS prices $175,000 trigger phoenix autocallables linked to CVS Caremark
|
2/7/2017 | SP | New Issue: UBS prices $200,000 trigger phoenix autocallables linked to CVS Caremark
|
2/2/2017 | SP | New Issue: UBS prices $250,000 trigger phoenix autocallables linked to CVS Caremark
|
12/16/2016 | SP | New Issue: UBS prices $160,000 trigger phoenix autocallables linked to CVS Caremark
|
12/16/2016 | SP | New Issue: UBS prices $180,000 trigger phoenix autocallables linked to CVS Caremark
|
11/8/2016 | SP | New Issue: UBS prices $150,000 trigger phoenix autocallables linked to CVS Caremark
|
11/8/2016 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to CVS Caremark
|
7/26/2016 | IGLM | CVS Caremark to redeem $1.09 billion of senior notes on July 27
|
12/31/2014 | LM | Outlook 2015: Merck, Simon Properties, CVS Caremark in big deals; M&A to impact deal flows
|
9/5/2014 | IGLM | CVS Caremark accepts tenders for $2 billion of four series of notes
|
8/21/2014 | IGLM | CVS Caremark gets tenders for $2.37 billion notes so far, sets pricing
|
8/8/2014 | IG | Market Commentary: Morning Commentary: High-grade bonds mixed; CVS firms; Bank of America, Verizon mostly flat
|
8/7/2014 | IG | New Issue: CVS Caremark sells $1.5 billion of senior notes due 2019, 2024
|
8/7/2014 | EMHYMUPFPV | Market Commentary: Packed primary session sees Citigroup, CVS, Berkshire Hathaway price; bond spreads ease
|
8/7/2014 | IG | Market Commentary: Packed primary session sees Citigroup, CVS, Berkshire Hathaway price; bond spreads ease
|
8/7/2014 | IG | S&P rates CVS Caremark notes BBB+
|
8/7/2014 | IG | Market Commentary: Morning Commentary: High-grade bond spreads steady ahead of supply; bank paper flat to softer
|
8/7/2014 | IGLM | CVS Caremark tenders for all 6.25% notes, up to cap for three series
|
8/7/2014 | IG | CVS Caremark eyeing two-part benchmark issue of senior notes Thursday
|
12/9/2013 | IG | Market Commentary: Discover Bank prices add-on during muted session; Discover Bank, CVS notes tighten
|
12/2/2013 | IG | New Issue: CVS Caremark prices $4 billion of senior notes in four parts
|
12/2/2013 | IG | Market Commentary: Johnson & Johnson, CVS, Starbucks bring new deals; Starbucks firms in secondary
|
12/2/2013 | IG | CVS Caremark eyeing issue of senior notes in four tranches
|
11/27/2013 | IG | Moody's: CVS Caremark unchanged
|
9/23/2013 | IG | Moody's lifts CVS to Baa1
|
2/21/2013 | SP | New Issue: Credit Suisse sells $350,000 callable contingent coupon notes on stocks
|
2/19/2013 | SP | Correction: Credit Suisse plans contingent coupon notes tied to stocks
|
2/15/2013 | SP | Barclays plans callable contingent coupon notes linked to four stocks
|
12/24/2012 | IGLM | CVS Caremark holders tender $1.74 billion of notes by offers' end
|
12/10/2012 | IGLM | CVS Caremark prices offers for $1 billion notes; tender cap lifted
|
11/26/2012 | IG | Market Commentary: Amazon.com does bond deal after long absence; Cox, CVS price; Amazon notes firm in gray market
|
11/26/2012 | IGLM | CVS Caremark begins tender offer for $1 billion of three note series
|
11/26/2012 | HY | Market Commentary: No dollar deals price, though Inergy, Clean Harbors, Era Group slate; ArcelorMittal busy
|
11/26/2012 | IG | CVS Caremark to tap market for 10-year senior notes on Monday
|
11/26/2012 | IG | New Issue: CVS Caremark sells $1.25 billion 2.75% 10-year notes at Treasuries plus 110 bps
|
5/31/2012 | IG | Moody's: CVS Caremark view positive
|
4/30/2012 | SP | New Issue: Morgan Stanley prices $210,500 trigger phoenix autocallables linked to CVS Caremark
|
4/24/2012 | SP | Morgan Stanley plans trigger phoenix autocallables linked to CVS
|
2/9/2012 | CVIG | Moody's: No changes for CVS/Caremark
|
12/7/2011 | IG | Market Commentary: Viacom, ERP price as Citi reopens debt, First Niagara does preferreds; Transocean firms
|
12/7/2011 | IGLMPF | CVS Caremark receives tenders for $957.72 million 6.302% preferreds
|
12/6/2011 | CVIG | Fitch affirms CVS Caremark
|
11/29/2011 | IGLMPF | CVS Caremark launches tender offer for $1 billion 6.302% preferreds
|
8/24/2011 | IG | Moody's: CVS Caremark unaffected
|
8/22/2011 | IGLM | CVS Caremark 6 1/8% noteholders deliver consents to terminate replacement capital covenant
|
7/22/2011 | IG | Moody's: CVS unchanged
|
5/12/2011 | IG | Market Commentary: SoCal Edison upsized deal, Gulf Power price as issuance drops; CVS Caremark, IBM trade wider
|
5/10/2011 | IG | New Issue: CVS Caremark gives terms of $1.5 billion senior notes sold in 10-, 30-year tranches
|
5/10/2011 | IG | Market Commentary: Bank of America, Philip Morris, Ventas keep primary flow alive; CVS weak; Gap 30 bps wider
|
5/9/2011 | IG | S&P ups CVS to stable
|
5/9/2011 | IG | Market Commentary: High-grade market hit with wave of deals; IBM, CVS among sellers; Nevada Power firms 6 bps
|
5/9/2011 | IG | New Issue: CVS Caremark sells upsized $1.5 billion senior notes in 10-, 30-year tranches
|
1/3/2011 | IG | Moody's affirms CVS Caremark
|
1/3/2011 | IG | S&P: CVS Caremark unchanged
|
12/31/2010 | IG | Fitch affirms CVS
|
12/10/2010 | IG | S&P: CVS certificates at BBB+
|
11/3/2010 | SP | New Issue: UBS prices $1 million 7.73% yield optimization notes linked to CVS Caremark
|
11/1/2010 | SP | New Issue: Credit Suisse prices $1.5 million contingent coupon autocallable notes linked to five stocks
|
10/21/2010 | SP | Credit Suisse plans contingent coupon callable notes on five stocks
|
10/15/2010 | IG | S&P: CVS unaffected
|
10/8/2010 | IG | CVS Caremark projecting increased free cash flow, looks to maintain leverage ratio, credit ratings
|
7/30/2010 | SP | New Issue: HSBC sells $5.79 million 8.64% yield optimization notes on CVS Caremark via UBS
|
7/22/2010 | SP | New Issue: JPMorgan prices $500,000 10.75% reverse convertibles linked to CVS Caremark
|
7/21/2010 | SP | HSBC plans 7.5%-9.5% yield optimization notes tied to CVS via UBS
|
7/19/2010 | SP | New Issue: RBS sells $2.35 million 16.25% reverse exchangeables tied to CVS Caremark
|
6/25/2010 | IG | Moody's: CVS unchanged
|
6/14/2010 | IG | Moody's: CVS Caremark unchanged
|
5/13/2010 | IG | New Issue: CVS Caremark sells $1 billion of notes in five-, 10-year tranches
|
5/13/2010 | IG | Fitch rates CVS Caremark notes BBB+
|
5/13/2010 | IG | Market Commentary: CVS, FPL, PNC price notes, primary spreads remain tight; new deals up; Goldman better, BP not
|
3/24/2010 | CVIG | CVS Caremark files automatic shelf registration for debt securities
|
1/13/2010 | BWIG | CVS Caremark projecting 'significant' cash flow over five years; internal projects top priority
|
1/5/2010 | IG | Market Commentary: Foreigners Dexia, Barclays, Lloyds, KfW tap market, GE Capital lone domestic; spreads tighten
|
12/22/2009 | IG | Market Commentary: Investment-grade financials lead stronger market amid light volume; primary on vacation
|
12/11/2009 | IG | Moody's rates CVS certificates Baa2
|
12/10/2009 | IG | Fitch affirms CVS Caremark
|
12/7/2009 | IG | New Issue: CVS unit prices $744 million 7.507% pass-throughs due 2032 at par
|
12/7/2009 | IG | Market Commentary: BlackRock, Westpac Banking, USB Capital, CVS price deals; secondary loses volume, focus
|
11/24/2009 | IG | Moody's cuts CVS outlook to stable
|
11/6/2009 | IG | S&P cuts CVS outlook to negative
|
11/6/2009 | IG | Market Commentary: Bank of NY Mellon, Eksportfinans price; coming week seen busy; secondary quiets on slim supply
|
11/5/2009 | IG | Market Commentary: FPL Group, Regions Financial, Nordea Bank price bonds, primary tone flat; CVS Caremark wider
|
9/9/2009 | IG | Market Commentary: Handelsbanken, Timken, Agilent, Swedish Export, National Rural sell bonds; spreads steady
|
9/9/2009 | IG | Fitch gives BBB+ to CVS Caremark notes
|
9/8/2009 | IG | New Issue: CVS Caremark prices $1.5 billion 6.125% 30-year notes at Treasuries plus 187.5 bps
|
9/8/2009 | IG | Market Commentary: Iberdrola Ireland, Airgas, AvalonBay, CVS, Puget Sound sell bonds; Kraft wider on Cadbury bid
|
8/17/2009 | IG | Market Commentary: Baxter, MeadWestvaco, HSBC Finance offer notes; new industrials improve, financials struggle
|
7/27/2009 | SS | Market Commentary: Agilent to buy Varian in all-cash deal; Aetna sale rumors surface; El Paso secures partner
|
6/26/2009 | IG | S&P rates CVS passthrough certs BBB+
|
4/13/2009 | SS | Market Commentary: Express Scripts up on WellPoint buyout offer; CF gains RiskMetrics vote; Agrium pushes ahead
|
3/10/2009 | IG | New Issue: CVS Caremark sells $1 billion 6.6% 10-year notes at Treasuries plus 370 bps
|
3/10/2009 | IG | Fitch rates CVS notes BBB+
|
3/10/2009 | IG | Market Commentary: Halliburton, Boeing, CVS, KeyCorp, Morgan Stanley among day's sales; Medtronic tightens
|
1/20/2009 | SP | JPMorgan to price 11% reverse exchangeables linked to CVS Caremark
|
12/31/2008 | SP | New Issue: Barclays prices $3.5 million 17% reverse convertibles linked to CVS Caremark
|
12/8/2008 | SP | Barclays to price 17% reverse convertibles linked to CVS Caremark
|
11/20/2008 | SS | Walgreen plan to slow store growth should positively impact earnings, says Barrington Research's Leckow
|
10/30/2008 | SS | CVS Caremark, Longs Drug combine
|
10/29/2008 | SS | CVS Caremark to acquire Longs by end of week
|
10/28/2008 | SS | Advisory Research tenders shares in CVS Caremark's offer for Longs Drug
|
10/20/2008 | SS | CVS Caremark accepts 76.51% of Longs Drug's shares, begins subsequent tender offer
|
10/17/2008 | SS | CVS Caremark once again extends offer, 77.55% of Longs outstanding shares tendered to date
|
10/17/2008 | SS | Market Commentary: Ballmer's comments add billions in value; Modelo jockeys for better deal; GM, Chrysler merger rumors
|
10/16/2008 | SS | CVS Caremark extends offer; 65.88% of Longs' outstanding shares tendered to date
|
10/16/2008 | SS | Market Commentary: Ballmer resurrects Yahoo! deal talk; Swiss back banks; CVS extends tender
|
10/10/2008 | SS | Advisory Research backs CVS bid for Longs, sells 4,560 shares
|
10/10/2008 | SS | Market Commentary: Wells Fargo emerges as Wachovia winner; Rectifier holders rebuff Vishay; key Longs holder falls into line
|
10/9/2008 | SS | Market Commentary: Apollo offers up $540 million for Huntsman, Hexion deal; Walgreens withdraws; banks talk, shares fall
|
10/8/2008 | SS | Market Commentary: Walgreen walks away from Longs Drug bid; Service Corp-Stewart deal dead; Wachovia truce extended
|
10/8/2008 | SS | Walgreen drops bid for Longs Drug
|
10/3/2008 | SS | CtW Investment denies CVS Caremark claims
|
10/1/2008 | SS | Advisory Research weighs in on FTC's request for information on Walgreen's offer for Longs Drug
|
9/29/2008 | SS | CtW Investment at odds with Longs Drug's refusal to negotiate with Walgreen
|
9/25/2008 | SS | FTC examines competition issues related to merger of Longs with Walgreen or CVS Caremark
|
9/23/2008 | SS | Longs continues to urge shareholders to tender shares in CVS Caremark offer despite Walgreen's interest
|
9/23/2008 | SS | Market Commentary: Investors watch WaMu; Icahn fights for ImClone; Longs Drug Stores readies for Walgreen hostile bid
|
9/22/2008 | SS | Walgreen ready to take offer directly to Longs Drug shareholders
|
9/17/2008 | SS | Market Commentary: AIG joins the Treasury roll; more bank deals brewing; Longs Drug Stores, SanDisk reject offers
|
9/17/2008 | SS | No negotiations for Longs Drug, Walgreen
|
9/16/2008 | SS | CtW pushes for auction of Longs Drug Stores
|
9/15/2008 | IG | S&P: CVS/Caremark unaffected
|
9/15/2008 | SS | CVS Caremark extends offer for Longs on news of Walgreen's $75-per-share bid
|
9/15/2008 | SS | Market Commentary: AIG slides amid rescue talks, Fed nix on loan; Electronic Arts walks from Take-Two; Longs mulls bids
|
9/12/2008 | SS | Walgreen offers $75 per share for Longs Drug, topping CVS proposal
|
9/12/2008 | SS | Advisory Research will not tender Longs Drug Stores shares in CVS Caremark offer
|
9/12/2008 | SS | Market Commentary: Lehman, WaMu stutter along; King tenders for Alpharma; Longs holders shun CVS as Walgreen steps in
|
9/11/2008 | SS | Longs Drugs investor Pershing Square opposes deal with CVS, identifies other possible buyers
|
9/8/2008 | SS | Merger of CVS Caremark, Longs Drugs one step closer to completion
|
9/5/2008 | IG | Market Commentary: CVS, Procter & Gamble price floaters; active calendar ahead; utilities tighten in weak secondary
|
9/5/2008 | IG | New Issue: CVS Caremark prices $350 million two-year floaters to yield Libor plus 150 bps
|
9/4/2008 | SS | Market Commentary: CVS confident of Longs offer; speculation swirls around Lehman; SunOpta plans strategic review
|
9/3/2008 | SS | CtW Investment questions CVS Caremark's valuation of Longs Drugs
|
8/21/2008 | SS | Market Commentary: Longs pushes, CVS holds ground; Take-Two, Electronic Arts map a friendly offer
|
8/14/2008 | SS | Market Commentary: CME keeps shareholder meeting Monday as planned; UnionBanCal rejects Bank of Tokyo-Mitsubishi offer
|
8/13/2008 | IG | S&P affirms CVS Caremark
|
8/13/2008 | IG | Moody's affirms CVS Caremark
|
8/13/2008 | SS | Market Commentary: eBay bids for Gmarket; Longs jumps on CVS offer; Genetech spurns Roche offer
|
8/12/2008 | IG | Fitch affirms CVS
|
8/12/2008 | SS | CVS Caremark to acquire Longs Drug for $2.9 billion
|
7/17/2008 | SP | UBS to price autocallable optimization securities linked to CVS Caremark
|
6/27/2008 | IG | Fitch upgrades CVS Caremark
|
5/22/2008 | IG | Moody's: CVS Caremark unaffected
|
5/21/2008 | IG | Fitch: CVS Caremark unaffected
|
5/15/2008 | IG | Moody's lifts CVS outlook to positive
|
4/11/2008 | IG | Market Commentary: American Express Bank, Korea Southern Power price; tone sours on GE earnings news amid issuance lull
|
1/29/2008 | SP | New Issue: Lehman sells $1.04 million 10% reverse exchangeables linked to CVS Caremark
|
12/11/2007 | IG | New Issue: CVS prices $593 mln 6.943% pass-through certificates due 2030 at Treasuries plus 312.5 bps
|
12/11/2007 | IG | Market Commentary: AIG, AGL, BP price as Fed cuts rates a disappointing 25 bps, market softens on news
|
12/7/2007 | IG | Market Commentary: AIG, Principal Life, Diageo issue at end of week with more than $30 billion pricing
|